MC2 Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsMC2 Therapeutics

MC2 Therapeutics

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Wynzora	Betamethasone, Calcipotriene	2020-07-20	2027-2039	Psoriasis , Atopic dermatitis , Pruritus ani , Inflammation , Facial dermatoses , Seborrheic dermatitis , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses , Mycoses , Oral candidiasis , Vulvovaginal candidiasis , Tinea pedis , Cutaneous candidiasis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

allergic rhinitis

,

,

allergic rhinitis perennial

Microcrystalline cellulose

systemic lupus erythematosus

,

cutaneous lupus erythematosus

,

,

b-cell lymphoma

,

non-hodgkin lymphoma

,

large b-cell lymphoma diffuse

,

graft vs host disease

,

bronchiolitis obliterans syndrome

,

,

actinic keratosis

,

plantar fasciitis

,

,

healthy volunteers/patients

,

clostridium botulinum type a

,

vasoconstriction

,

,

photoallergic dermatitis

,

phototoxic dermatitis

,

amyotrophic lateral sclerosis

,

motor neuron disease

,

,

ataxia telangiectasia

,

,

rotator cuff injuries

,

,

connective tissue diseases

,

skin and connective tissue diseases

,

keratoconjunctivitis sicca

,

dry eye syndromes

,

,

,

,

wounds and injuries

,

,

,

colorectal neoplasms

,

non-small-cell lung carcinoma

,

,

,

,

,

aphthous stomatitis

,

,

sprains and strains

,

,

,

behcet syndrome

,

,

,

elbow tendinopathy

,

respiratory distress syndrome

,

newborn respiratory distress syndrome

,

,

contact dermatitis

,

hip osteoarthritis

,

obstetric labor complications

,

,

oral submucous fibrosis

,

,

,

,

allergic contact dermatitis

,

,

,

,

,

,

,

seborrheic dermatitis

,

retinal vein occlusion

,

pregnancy outcome

,

graves ophthalmopathy

,

thyroid diseases

,

pigmentation disorders

,

,

,

adenoviridae infections

,

,

,

atopic dermatitis

,

,

,

premature birth

,

knee osteoarthritis

,

,

,

,

,

,

oral lichen planus

,

,

carpal tunnel syndrome

,

,

,

alopecia areata

,

,

,

premature obstetric labor

,

,

postoperative pain

,

,

,

,

pregnancy complications

,

,

,

neurosurgical procedures

,

insulin resistance

,

postoperative nausea and vomiting

,

,

,

eczematous skin diseases

,

,

erythema multiforme

,

granulomatous mastitis

,

,

immunoglobulin g4-related disease

,

trigger finger disorder

,

temporomandibular joint disorders

,

,

temporomandibular joint dysfunction syndrome

,

,

,

radiodermatitis

,

,

hyaline membrane disease

,

shoulder impingement syndrome

,

hypertrophic cicatrix

,

,

,

,

cerebral intraventricular hemorrhage

,

infant mortality

,

lichen sclerosus et atrophicus

,

vision disorders

,

,

topical administration

,

,

giant cell arteritis

,

polymyalgia rheumatica

,

transient tachypnea of the newborn

,

,

respiratory function tests

,

functional residual capacity

,

discoid lupus erythematosus

,

systemic lupus erythematosus

,

,

autoimmune diseases

,

central nervous system sensitization

,

intra-articular injections

,

neurodermatitis

,

failed back surgery syndrome

,

intervertebral disc displacement

,

periodontal diseases

,

pain management

,

replacement arthroplasty knee

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use